BetterLife Pharma - CEO, Ahmad Doroudian.

" BetterLife files patent for treatment of cluster headaches and related disorders

BetterLife Pharma (BETR) has applied for patent protection of new compositions of 2-bromo-LSD.
BetterLife Pharma - CEO, Ahmad Doroudian.

" BetterLife (CSE:BETR) enrolls first patient in Interferon alpha-2b COVID-19 trial

The first patient has been enrolled in BetterLife’s (BETR) Interferon alpha-2b COVID-19 trial in Chile.
BetterLife Pharma - CEO, Ahmad Doroudian.

" BetterLife Pharma (CSE:BETR) initiates preclinical study against Delta variant

BetterLife Pharma (BETR) has initiated a preclinical study of AP-003 (rhIFNa2b) against the Delta variant of SARS-CoV-2.
BetterLife Pharma - CEO, Ahmad Doroudian.

" BetterLife’s (CSE:BETR) AP-003 shown to be effective against COVID-19 variants

BetterLife’s (BETR) AP-003 has shown similar efficacy against COVID-19 variants in a preclinical study.